| Financial Year |
March 31 2023 |
| Monetary Funds |
10,142,235,828.96 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,360,000.00 |
| Accounts Receivable |
1,421,824,204.10 |
| Advances to Suppliers |
333,042,309.17 |
| Other Receivables |
142,382,425.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,282,624,346.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
85,940,666.78 |
| Other Current Assets |
76,648,072.75 |
| Total Current Assets |
13,498,704,084.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
136,500,217.99 |
| Long-term Equity Investment |
1,363,821,915.49 |
| Investment Properties |
38,318,977.87 |
| Fixed Assetes |
672,020,281.50 |
| Under-construction Projects |
406,842,392.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
229,521,831.47 |
| R&D expenses |
-- |
| Goodwill |
23,877,815.22 |
| Long-Term Deferred and Prepaid Expenses |
109,109,598.77 |
| Deferred Income Tax Assets |
10,627,322.15 |
| Other Non-Current Assets |
12,125,195.56 |
| Sub-Total of Non-Current Assets |
4,800,377,865.74 |
| Total Assets |
18,299,081,950.23 |
| Short-Term Loans |
112,778,046.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
185,850.00 |
| Accounts Payable |
3,564,185,992.28 |
| Accounts Received In Advance |
20,729,645.04 |
| Employee Compensation Payable |
531,225,004.86 |
| Taxes Payable |
32,895,007.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
129,612,648.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
176,134,391.77 |
| Other Current Liabilities |
93,824,867.84 |
| Sub-Total of Current Liabilities |
5,704,069,986.25 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
28,383,367.67 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
6,062,985.16 |
| Sub-Total of Non-Current Liabilities |
909,850,942.81 |
| Total Liabilities |
6,613,920,929.06 |
| Paid-In Capital(Or Share Stock) |
1,989,204,737.00 |
| Capital Surplus |
2,446,300,424.03 |
| Surplus Reserve |
1,532,088,658.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,766,312,636.15 |
| Minority Stockholder's Interest |
150,877,660.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,534,283,361.13 |
| Owner's Equity（Stockholder's Equity） |
11,685,161,021.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,299,081,950.23 |
